Battle-Tested AIRO RQ-35 Heidrun Secures U.S. Blue UAS Approval
The combat-proven ISR drone is now cleared for easier procurement by U.S. government and military customers.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
The combat-proven ISR drone is now cleared for easier procurement by U.S. government and military customers.
Includes Erinyes, Zeus, and Oriole technologies as the company accelerates high-speed defense capabilities.
Strong AI-driven HBM demand and tight supply outlook expected into 2027-2028.
Revenue jumped 39% to $20.34B while EPS hit $20.98, crushing Wall Street forecasts.
BofA posted robust Q2 2026 earnings, beating expectations with $9.1 billion profit and 33% growth in sales & trading. Equity trading surged 70% as market volatility boosted activity.
IBM cut its Q2 revenue and earnings forecast as AI spending shifts hurt traditional software and services. CEO admits slow adaptation to market changes.